Skip to main content

Table 2 Differences between infrequent and frequent developers over twelve years

From: Twelve years of clinical practice guideline development, dissemination and evaluation in Canada (1994 to 2005)

 

Total developers n = 96

Difference

 

Infrequent developers

n = 55

% (95% CI)

Frequent developers

n = 41

% (95% CI)

%

Scientific literature reviewed

94.1 (89.0–99.2)

97.3 (96.4–98.2)

3.2

Computerized literature search

76.6 (66.9–86.3)

91.6 (90.1–93.2)

15.0

Search strategy stated in guideline

37.1 (25.5–48.8)

37.3 (34.6–40.1)

0.2

Quality of evidence graded

38.1 (27.5–48.7)

51.6 (48.8–54.4)

13.5

Passive dissemination strategies

90.6 (84.3–96.9)

91.4 (89.8–92.9)

0.8

Educational strategies

45.8 (35.1–56.7)

48.3 (45.5–51.1)

2.5

Active implementation strategies

29.4 (19.5–39.3)

33.0 (30.4–35.6)

3.6

Effectiveness of dissemination/implementation strategies formally evaluated

3.7 (0–7.8)

9.2 (7.6–10.8)

5.5

Plan to evaluate dissemination/implementation in future

29 (17.4–40.7)

44.4 (41.2–47.6)

15.4

Formally evaluated impact on health outcomes

6.1 (0.8–11.4)

14.1 (12.1–16)

8.0

Plan to evaluate impact on health outcomes in future

32.3 (20.3–44.2)

43.9 (40.7–47.1)

11.6

Companion consumer version

12.9 (5.7–20.2)

25.4 (23–27.8)

12.5

Plan to produce consumer version in future

7.1 (1.5–12.6)

20.5 (18.3–22.7)

13.4